Wellcome Moves Major Funding Schemes to Rolling Applications
Wellcome TrustWellcome is removing fixed deadlines from three major funding schemes, allowing researchers to submit applications whenever they are ready.
Research News
Tau Studies Point to New Alzheimer’s Tests and Treatments
Dementia ResearcherThe CELIA trial found diranersen reduced tau and showed signs of slowing decline, while separate research linked blood tau with future Alzheimer’s risk.
Blood Test May Predict Alzheimer’s Risk 10 Years Early
Alzheimer's AssociationA blood test measuring p-tau217 may predict Alzheimer’s-related cognitive decline up to a decade before symptoms appear, AAIC 2026 research finds.
Alzheimer’s Blood Test Could Transform Diagnosis
New data suggest an Alzheimer’s blood test could help primary care doctors diagnose the disease with around 90% accuracy, matching specialists. #AAIC26
LiBBY Trial: THC/CBD Reduces End-of-Life Agitation
Phase 2 LiBBY trial results suggest a THC/CBD combination rapidly and significantly reduces agitation in hospice-eligible people with dementia. #AAIC26
PROTECT-Cog Tests Lifestyle and GLP-1 for Cognitive Decline
A new $100m global trial will test whether combining lifestyle support with GLP-1 or similar drugs can reduce cognitive decline and dementia risk.
Lifestyle Programme Boosts Brain Health Across Latin America
Lifestyle changes improved memory and thinking in older adults at risk of dementia across Latin America, with coaching delivering the strongest gains.
Former Elite Soccer Players Show Evidence of Brain Health Changes in Mid-Life
Research presented by Caleigh Grace Lynch presneted at AAIC provides insights into brain health among former elite professional soccer players during midlife.
Dementia Researcher X ISTAART Relay 2026: Complete Series
Six podcast episodes and two Relay Live specials introducing ISTAART Professional Interest Areas, dementia researchers and the topics shaping AAIC 2026.
Meet the New Alzheimer’s Society Awardees
Alzheimer's SocietyMeet Alzheimer’s Society’s new dementia research awardees and hear how their projects aim to improve diagnosis, care, prevention and brain health.
Research from the ARUK Thames Valley Conference
Watch the main plenary and five flash talks from the ARUK Thames Valley Research Conference, covering dementia science from cells to care.
AI Enabled Trials in Neurodegeneration: London Summit Insights
LifeArc and the DEMON Network share talks from the London Summit on AI Enabled Trials in Neurodegeneration, covering AI, trial design and remote trials.